» Articles » PMID: 17991208

Racial and Ethnic Disparities in End-stage Kidney Failure-survival Paradoxes in African-Americans

Overview
Journal Semin Dial
Specialty Nephrology
Date 2007 Nov 10
PMID 17991208
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

The risk of death is nearly 45% lower in African-Americans than Caucasians undergoing chronic hemodialysis. In light of the higher mortality rate in African-Americans in the general US population, this paradox requires explanation and further investigation. Factors that may contribute to this survival advantage include a younger age at which African-Americans arrive at end-stage renal disease (ESRD) and the slightly higher body mass index. On the other hand, factors, such as lower residual renal function, lower mean hemoglobin and hematocrit, increased prevalence of hypertension, a higher prevalence of catheter use for initial dialysis, and generally lower dose of dialysis should put African-Americans on dialysis at a higher risk of death. This survival advantage seems to be completely annulled with a successful renal transplant. Finally, it should be noted that ESRD carries with it a very high mortality rate in all racial and ethnic groups. A successful renal transplant improves but does not restore the expected remaining life times. Therefore, aggressive approach is required in investigating the factors that confer such high mortality risk on ESRD patients.

Citing Articles

Remaining life expectancy of Korean hemodialysis patients: how much longer can they live?.

Park H, Kim D, Cho A, Kim B, Lee M, Kim G Kidney Res Clin Pract. 2024; 43(5):671-679.

PMID: 38389145 PMC: 11467359. DOI: 10.23876/j.krcp.23.241.


Pressure Ulcer Diagnosis Is Associated with Increased Mortality in Patients with End-Stage Renal Disease: A Retrospective Study.

Duchesne G, Waller J, Baer S, Young L, Bollag W Life (Basel). 2023; 13(8).

PMID: 37629570 PMC: 10456114. DOI: 10.3390/life13081713.


Race and Mortality in Hemodialysis Patients in Brazil.

Barreto Lopes M, Silveira-Martins M, Albuquerque da Silva F, Silva L, Silva-Martins M, Matos C Kidney Med. 2022; 4(12):100557.

PMID: 36438025 PMC: 9681633. DOI: 10.1016/j.xkme.2022.100557.


Serum Cystatin-C is linked to increased prevalence of diabetes and higher risk of mortality in diverse middle-aged and older adults.

Gonzalez K, Stickel A, Kaur S, Ramos A, Gonzalez H, Tarraf W PLoS One. 2022; 17(9):e0270289.

PMID: 36094936 PMC: 9467319. DOI: 10.1371/journal.pone.0270289.


Physical Resilience Phenotype Trajectories in Incident Hemodialysis: Characterization and Mortality Risk Assessment.

Hladek M, Zhu J, Crews D, McAdams-DeMarco M, Buta B, Varadhan R Kidney Int Rep. 2022; 7(9):2006-2015.

PMID: 36090502 PMC: 9459128. DOI: 10.1016/j.ekir.2022.06.009.